Literature DB >> 8633137

Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT.

M A King1, J A Stone, P T Diaz, C F Mueller, W J Becker, J E Gadek.   

Abstract

PURPOSE: To assess bronchiectasis depicted with computed tomography (CT) in patients with alpha 1-antitrypsin deficiency and to examine associated clinical correlates.
MATERIALS AND METHODS: CT scans in 14 patients with alpha 1-antitrypsin deficiency were evaluated by two thoracic radiologists for the presence and extent of bronchiectasis and emphysema. The findings were correlated with numeric infection scores on the basis of symptoms of sputum production and respiratory infection and with a history of conditions that may predispose to development of bronchiectasis.
RESULTS: Six (43%) of 14 patients had CT evidence of bronchiectasis. Patients with bronchiectasis had significantly higher infection scores than did patients without bronchiectasis (P < .005). Two patients had diffuse cystic bronchiectasis, and neither reported a history of illness that may have predisposed them to this condition.
CONCLUSION: Bronchiectasis may be more common in patients with alpha 1-antitrypsin deficiency than has been previously recognized. The diagnosis of alpha 1-antitrypsin deficiency should be considered in patients with emphysema and diffuse cystic bronchiectasis.

Entities:  

Mesh:

Year:  1996        PMID: 8633137     DOI: 10.1148/radiology.199.1.8633137

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

Review 1.  Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema.

Authors:  R Mahadeva; D A Lomas
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

2.  Images in COPD: Alpha-1 Antitrypsin Deficiency and Bronchiectasis.

Authors:  Scott Simpson; Friedrich Kueppers; Robert M Steiner
Journal:  Chronic Obstr Pulm Dis       Date:  2016-04-07

3.  Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.

Authors:  R Mahadeva; W S Chang; T R Dafforn; D J Oakley; R C Foreman; J Calvin; D G Wight; D A Lomas
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

4.  Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease.

Authors:  R Mahadeva; S Stewart; D Bilton; D A Lomas
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 5.  Disease modifying genes in cystic fibrosis: therapeutic option or one-way road?

Authors:  Rainer Büscher; Hartmut Grasemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-11       Impact factor: 3.000

Review 6.  Pathophysiology and Genetics of Bronchiectasis Unrelated to Cystic Fibrosis.

Authors:  Aleksandra Nikolic
Journal:  Lung       Date:  2018-05-12       Impact factor: 2.584

7.  Quantitative airway assessment on computed tomography in patients with alpha1-antitrypsin deficiency.

Authors:  Tsuneo Yamashiro; Shin Matsuoka; Raúl San José Estépar; Alejandro Diaz; John D Newell; Robert A Sandhaus; Patricia J Mergo; Mark L Brantly; Sadayuki Murayama; John J Reilly; Hiroto Hatabu; Edwin K Silverman; George R Washko
Journal:  COPD       Date:  2009-12       Impact factor: 2.409

Review 8.  Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history.

Authors:  M Needham; R A Stockley
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

Review 9.  Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.

Authors:  D A Lomas; H Parfrey
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

Review 10.  Alpha-1-antitrypsin deficiency: current concepts.

Authors:  Alan T Mulgrew; Clifford C Taggart; N Gerry McElvaney
Journal:  Lung       Date:  2007-06-12       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.